Logo image of DWAC

DIGITAL WORLD ACQUISITION-A (DWAC) Stock Fundamental Analysis

NASDAQ:DWAC - Nasdaq - US25400Q1058 - Common Stock - Currency: USD

49.95  +13.01 (+35.22%)

After market: 53.75 +3.8 (+7.61%)

Fundamental Rating

1

DWAC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. DWAC has a bad profitability rating. Also its financial health evaluation is rather negative. DWAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year DWAC has reported negative net income.
DWAC had a negative operating cash flow in the past year.
DWAC Yearly Net Income VS EBIT VS OCF VS FCFDWAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 -5M -10M -15M

1.2 Ratios

Industry RankSector Rank
ROA -8.12%
ROE -10.22%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DWAC Yearly ROA, ROE, ROICDWAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 -1 -2 -3 -4 -5

1.3 Margins

DWAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DWAC Yearly Profit, Operating, Gross MarginsDWAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DWAC remains at a similar level compared to 1 year ago.
The debt/assets ratio for DWAC is higher compared to a year ago.
DWAC Yearly Shares OutstandingDWAC Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 10M 20M 30M
DWAC Yearly Total Debt VS Total AssetsDWAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 100M 200M 300M

2.2 Solvency

An Altman-Z score of 16.62 indicates that DWAC is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.02 indicates that DWAC is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 16.62
ROIC/WACCN/A
WACCN/A
DWAC Yearly LT Debt VS Equity VS FCFDWAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M 200M 250M

2.3 Liquidity

DWAC has a Current Ratio of 0.06. This is a bad value and indicates that DWAC is not financially healthy enough and could expect problems in meeting its short term obligations.
DWAC has a Quick Ratio of 0.06. This is a bad value and indicates that DWAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
DWAC Yearly Current Assets VS Current LiabilitesDWAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 5M 10M 15M 20M

0

3. Growth

3.1 Past

The earnings per share for DWAC have decreased strongly by -133.74% in the last year.
EPS 1Y (TTM)-133.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DWAC Yearly Revenue VS EstimatesDWAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022
DWAC Yearly EPS VS EstimatesDWAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022

0

4. Valuation

4.1 Price/Earnings Ratio

DWAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DWAC Price Earnings VS Forward Price EarningsDWAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DWAC Per share dataDWAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DWAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DIGITAL WORLD ACQUISITION-A

NASDAQ:DWAC (3/25/2024, 8:19:28 PM)

After market: 53.75 +3.8 (+7.61%)

49.95

+13.01 (+35.22%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners46.25%
Inst Owner Change2.01%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap0
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.53
P/tB 7.53
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS6.63
TBVpS6.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.12%
ROE -10.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 16.62
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-227.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-182.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.32%
OCF growth 3YN/A
OCF growth 5YN/A